Abstract
68Ga labelled peptides are increasingly being used clinically due to widespread availability of 68Ge/68Ga generators and their recognised importance in the diagnosis of neuroendocrine tumours. A simple and reproducible GMP-compliant process for labelling peptides with generator-produced 68Ga is crucial to meet current pharmaceutical requirements. Here, we describe the development of a cassette-based 68Ga-radiolabelling process using an automated commercial synthesizer coupled with a standard 68Ge/68Ga generator. The radiolabeled somatostatin analogue [68Ga]DOTA-NOC was successfully synthesized in about 30 min with 80.3 ± 3.20 % of decay corrected radiochemical yield. The process is easily adaptable to the labelling of other peptides such as DOTA-TOC or DOTA-TATE for diagnosis or therapy.
Similar content being viewed by others
References
Al-Nahhas A, Win Z, Szyszko T, Singh A, Khan S, Rubello D (2007) Eur J Nucl Med Mol Imaging 34:1897–1901
Rosch F (2013) Appl Radiat Isot 76:24–30
Al-Nahhas A, Win Z, Szyszko T, Singh A, Khan S, Rubello D (2007) Anticancer Res 27:4087–4094
Breeman WA, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP (2005) Eur J Nucl Med Mol Imaging 32:478–485
Decristoforo C, Pickett RD, Verbruggen A (2012) Eur J Nucl Med Mol Imaging 39:S31–S40
Meyer GJ, Mäcke H, Schuhmacher J, Knapp WH, Hofmann M (2004) Eur J Nucl Med Mol Imaging 31:1097–1104
Banerjee SR, Pomper MG (2013) Appl Radiat Isot 76:2–13
Prata MI (2012) Curr Radiopharm 5:142–149
Putzer D, Kroiss A, Waitz D, Gabriel M, Traub-Weidinger T, Uprimny C, von Guggenberg E, Decristoforo C, Warwitz B, Widmann G, Virgolini IJ (2013) Eur J Nucl Med Mol Imaging 40:364–372
Breeman WA, de Blois E, Chan HS, Konijnenberg M, Kwekkeboom DJ, Krenning EP (2011) Semin Nucl Med 41:314–321
Froidevaux S, Eberle AN (2002) Somatostatin analogs and radiopeptides in cancer therapy. Pept Sci 66:161–183
Wild D, Schmitt JS, Ginj M, Mäcke HR, Bernard BF, Krenning E, de Jong M, Wenger S, Reubi J (2003) Eur J Nucl Med Mol Imaging 30:1338–1347
Teunissen JJ, Kwekkeboom DJ, Valkema R, Krenning EP (2011) Endocr Relat Cancer 18:S27–S51
Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rösch F (2007) J Nucl Med 48:1741–1748
Velikyan I, Beyer GJ, Långström B (2004) Bioconj Chem 15:554–560
Chopra A (2004) Molecular Imaging and Contrast Agent Database (MICAD). NCBI, Bethesda
European Commission (1995–2014) EudraLex Vol. 4—Good manufacturing practice (GMP) Guidelines. Brussels
Martins AF, Prata MIM, Rodrigues SPJ, Geraldes CFGC, Riss PJ, Amor-Coarasa A, Burchardt C, Kroll C, Roesch F (2013) Contrast Media Mol Imaging 8:265–273
Council of Europe (2014) European Pharmacopeia 8.0. EDQM, Strasbourg, pp 1062–1064
Council of Europe (2014) European Pharmacopeia 8.0. EDQM, Strasbourg, pp 1060–1062
Ocak M, Antrettera M, Knopp R, Kunkel F, Petrika M, Bergisadic N, Decristoforos C (2010) Appl Radiat Isot 68:297–302
Blom E, Koziorowski J (2012) Appl Radiat Isot 70:980–983
Mueller D, Klette I, Baum RP, Gottschaldt M, Schultz MK, Breeman WAP (2012) Bioconj Chem 23:1712–1717
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alves, V.H., Prata, M.I.M., Abrunhosa, A.J. et al. GMP production of 68Ga-labelled DOTA-NOC on IBA Synthera. J Radioanal Nucl Chem 305, 501–506 (2015). https://doi.org/10.1007/s10967-015-3989-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-015-3989-5